Genomics ‘Unconference’ Creates New Way to Foster Innovation
This fall, Duke University faculty launched the inaugural Alpine Genomics Institute Unconference, a three-day meeting, held in the mountains of Jackson Hole, Wyoming.
Duke at ASHG
The American Society of Human Genetics (ASHG) annual meeting is the largest human genetics and genomics meeting and exposition in the world. It provides a forum for presenting and discussing cutting-edge science in all areas of human genetics.
The meeting was held November 5-9 in Denver, Colorado. Several Duke faculty and trainees participated:
Striped gene expression pattern provides clues for neurodegenerative movement disorders
Spinocerebellar ataxias are a family of neurodegenerative disorders affecting muscle coordination and control.
Duke researchers are using single cell RNA sequencing technologies to better understand how these diseases form.
Duke-Led Model Identifies Pathogenic Variants in Cardiac Patients, Offers Diagnostic Hope
A new model developed by researchers at Duke University could help increase the number of patients receiving positive genetic test results, providing them with valuable information that could guide treatment decisions.
Genetic variants increase risk for chronic kidney disease in West Africans
Duke researchers led efforts in a collaborative case control and cohort study in Ghana and Nigeria on the prevalence of genetic risk factors for chronic kidney disease.
Shah Awarded Gill Heart and Vascular Institute Outstanding Contribuitions to Cardiovascular Research Award
Svati Shah, MD, Ursula Geller Distinguished Professor of Research in Cardiovascular Diseases, received the Gill Heart and Vascular Institute Outstanding Contributions to Cardiovascular Research Award from the University of Kentucky.
Svati Shah wins Gill Heart and Vascular Institute Award for Outstanding Contributions to Cardiovascular Research
The award recognizes notable and life-long achievements in research that have had a sustained impact on understanding cardiovascular biology and disease and/or that have changed the standard of cardiovascular clinical care.
Duke Center for Precision Health Awards Pilot Funding to Advance Genomic Science
The Duke Center for Precision Health and Precision Genomics Collaboratory have awarded five pilot grants to advance genomic science at Duke by leveraging and enhancing the OneDukeGen study infrastructure.
A Genomic Medicine Story (with only a little CRISPR)
While the Nobel-winning genome-editing technology CRISPR holds great promise, Duke’s Center for Advanced Genomic Technologies is putting some eggs in other baskets.
Weapon of Mass Congestion: Protection from Influenza Virus through Gene Control
The Defense Advanced Research Projects Agency (DARPA) is hoping to give people a different kind of superpower: protection from potentially lethal health threats